Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9048 |
High Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.8976 |
High Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.8846 |
High Similarity |
NPD1613 |
Approved |
0.8846 |
High Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.876 |
High Similarity |
NPD3027 |
Phase 3 |
0.8219 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8182 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.8125 |
Intermediate Similarity |
NPD1653 |
Approved |
0.811 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8015 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.8015 |
Intermediate Similarity |
NPD4749 |
Approved |
0.8015 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7985 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.7984 |
Intermediate Similarity |
NPD228 |
Approved |
0.7939 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7926 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7905 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7874 |
Intermediate Similarity |
NPD6671 |
Approved |
0.7869 |
Intermediate Similarity |
NPD968 |
Approved |
0.7868 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.7863 |
Intermediate Similarity |
NPD1091 |
Approved |
0.7847 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7778 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7754 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7748 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7744 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.774 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7737 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7733 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7661 |
Intermediate Similarity |
NPD290 |
Approved |
0.7632 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7594 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7578 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7552 |
Intermediate Similarity |
NPD3540 |
Phase 1 |
0.7533 |
Intermediate Similarity |
NPD4678 |
Approved |
0.7533 |
Intermediate Similarity |
NPD4675 |
Approved |
0.7516 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7516 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1940 |
Clinical (unspecified phase) |
0.7483 |
Intermediate Similarity |
NPD3539 |
Phase 1 |
0.7482 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7451 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7445 |
Intermediate Similarity |
NPD6917 |
Clinical (unspecified phase) |
0.7426 |
Intermediate Similarity |
NPD6696 |
Suspended |
0.7419 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7388 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.7386 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7375 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7361 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7333 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7329 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7324 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7324 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7317 |
Intermediate Similarity |
NPD1242 |
Phase 1 |
0.7312 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7301 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7266 |
Intermediate Similarity |
NPD4750 |
Phase 3 |
0.7266 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7266 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7258 |
Intermediate Similarity |
NPD291 |
Approved |
0.7248 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7241 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.723 |
Intermediate Similarity |
NPD2219 |
Phase 1 |
0.723 |
Intermediate Similarity |
NPD5307 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7218 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7215 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7211 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.7211 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7211 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7208 |
Intermediate Similarity |
NPD37 |
Approved |
0.72 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.72 |
Intermediate Similarity |
NPD4123 |
Phase 3 |
0.719 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7188 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7185 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7179 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7178 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7176 |
Intermediate Similarity |
NPD1398 |
Phase 1 |
0.7174 |
Intermediate Similarity |
NPD2922 |
Phase 1 |
0.7162 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7162 |
Intermediate Similarity |
NPD3892 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7134 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7133 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7133 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7133 |
Intermediate Similarity |
NPD1774 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6055 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD940 |
Approved |
0.712 |
Intermediate Similarity |
NPD846 |
Approved |
0.7115 |
Intermediate Similarity |
NPD6374 |
Clinical (unspecified phase) |
0.7114 |
Intermediate Similarity |
NPD2677 |
Approved |
0.7111 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7101 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7099 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7095 |
Intermediate Similarity |
NPD5177 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7091 |
Intermediate Similarity |
NPD7549 |
Discontinued |
0.7086 |
Intermediate Similarity |
NPD7447 |
Phase 1 |
0.708 |
Intermediate Similarity |
NPD1611 |
Approved |
0.7075 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7075 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7073 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7068 |
Intermediate Similarity |
NPD7157 |
Approved |
0.7063 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7063 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD3225 |
Approved |
0.705 |
Intermediate Similarity |
NPD8651 |
Approved |
0.7029 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7027 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7025 |
Intermediate Similarity |
NPD7975 |
Clinical (unspecified phase) |
0.702 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.702 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.702 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7015 |
Intermediate Similarity |
NPD7340 |
Approved |
0.7014 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7013 |
Intermediate Similarity |
NPD4005 |
Discontinued |
0.7007 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD8054 |
Approved |
0.7006 |
Intermediate Similarity |
NPD8053 |
Approved |
0.7 |
Intermediate Similarity |
NPD6190 |
Approved |
0.6986 |
Remote Similarity |
NPD4538 |
Approved |
0.6986 |
Remote Similarity |
NPD4537 |
Clinical (unspecified phase) |
0.6986 |
Remote Similarity |
NPD4536 |
Approved |
0.698 |
Remote Similarity |
NPD3060 |
Approved |
0.6974 |
Remote Similarity |
NPD1754 |
Clinical (unspecified phase) |
0.6972 |
Remote Similarity |
NPD5752 |
Clinical (unspecified phase) |
0.6968 |
Remote Similarity |
NPD4380 |
Phase 2 |
0.6963 |
Remote Similarity |
NPD1408 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5763 |
Approved |
0.6959 |
Remote Similarity |
NPD2029 |
Clinical (unspecified phase) |
0.6959 |
Remote Similarity |
NPD5762 |
Approved |
0.6959 |
Remote Similarity |
NPD1375 |
Discontinued |
0.6957 |
Remote Similarity |
NPD1535 |
Discovery |
0.6954 |
Remote Similarity |
NPD7124 |
Phase 2 |
0.695 |
Remote Similarity |
NPD6584 |
Phase 3 |
0.6944 |
Remote Similarity |
NPD2674 |
Phase 3 |
0.6939 |
Remote Similarity |
NPD1510 |
Phase 2 |
0.6933 |
Remote Similarity |
NPD3750 |
Approved |
0.6933 |
Remote Similarity |
NPD7473 |
Discontinued |
0.6923 |
Remote Similarity |
NPD7095 |
Approved |
0.6918 |
Remote Similarity |
NPD7075 |
Discontinued |
0.6918 |
Remote Similarity |
NPD1607 |
Approved |
0.6918 |
Remote Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.6908 |
Remote Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.6906 |
Remote Similarity |
NPD2235 |
Phase 2 |
0.6906 |
Remote Similarity |
NPD2231 |
Phase 2 |
0.6906 |
Remote Similarity |
NPD1481 |
Phase 2 |
0.6905 |
Remote Similarity |
NPD289 |
Clinical (unspecified phase) |
0.6901 |
Remote Similarity |
NPD9494 |
Approved |
0.6897 |
Remote Similarity |
NPD943 |
Approved |
0.6894 |
Remote Similarity |
NPD1247 |
Approved |
0.6892 |
Remote Similarity |
NPD6032 |
Approved |
0.6883 |
Remote Similarity |
NPD5403 |
Approved |
0.6879 |
Remote Similarity |
NPD2797 |
Approved |
0.6879 |
Remote Similarity |
NPD1203 |
Approved |
0.6875 |
Remote Similarity |
NPD3145 |
Approved |
0.6875 |
Remote Similarity |
NPD3144 |
Approved |
0.6875 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6871 |
Remote Similarity |
NPD6111 |
Discontinued |
0.6867 |
Remote Similarity |
NPD4237 |
Approved |
0.6867 |
Remote Similarity |
NPD4236 |
Phase 3 |
0.6867 |
Remote Similarity |
NPD4162 |
Approved |
0.6861 |
Remote Similarity |
NPD5585 |
Approved |
0.6853 |
Remote Similarity |
NPD600 |
Approved |
0.6853 |
Remote Similarity |
NPD596 |
Approved |
0.6852 |
Remote Similarity |
NPD3787 |
Discontinued |
0.6849 |
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.6849 |
Remote Similarity |
NPD1933 |
Approved |
0.6849 |
Remote Similarity |
NPD6355 |
Discontinued |
0.6849 |
Remote Similarity |
NPD5124 |
Phase 1 |
0.6835 |
Remote Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD5677 |
Discontinued |
0.6828 |
Remote Similarity |
NPD1726 |
Clinical (unspecified phase) |
0.6828 |
Remote Similarity |
NPD840 |
Approved |
0.6828 |
Remote Similarity |
NPD839 |
Approved |
0.6824 |
Remote Similarity |
NPD5960 |
Phase 3 |
0.6824 |
Remote Similarity |
NPD5588 |
Approved |
0.6824 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6824 |
Remote Similarity |
NPD6029 |
Clinical (unspecified phase) |
0.6824 |
Remote Similarity |
NPD6028 |
Clinical (unspecified phase) |
0.6818 |
Remote Similarity |
NPD5261 |
Clinical (unspecified phase) |
0.6815 |
Remote Similarity |
NPD709 |
Approved |
0.6813 |
Remote Similarity |
NPD4055 |
Discovery |
0.6812 |
Remote Similarity |
NPD17 |
Approved |
0.6812 |
Remote Similarity |
NPD6516 |
Phase 2 |
0.6812 |
Remote Similarity |
NPD5846 |
Approved |
0.6803
|
Remote Similarity |
NPD6653 |
Approved |